These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 3144367)

  • 1. Immunity to rubella in women of childbearing age in the United Kingdom.
    Noah ND; Fowle SE
    BMJ; 1988 Nov; 297(6659):1301-4. PubMed ID: 3144367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a rubella vaccination strategy: contribution of a rubella susceptibility study of women of childbearing age in Kyrgyzstan, 2001.
    Malakmadze N; Zimmerman LA; Uzicanin A; Shteinke L; Caceres VM; Kasymbekova K; Sozina I; Glasser JW; Joldubaeva M; Aidyralieva C; Icenogle JP; Strebel PM; Reef SE
    Clin Infect Dis; 2004 Jun; 38(12):1780-3. PubMed ID: 15227627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of rubella among women of childbearing age in Taiwan after nationwide vaccination.
    Su SB; Guo HR
    Am J Trop Med Hyg; 2002 Nov; 67(5):549-53. PubMed ID: 12479561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a vaccination programme on the distribution of rubella antibodies in women of childbearing age.
    Hambling MH
    Lancet; 1975 May; 1(7916):1130-3. PubMed ID: 49484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the prevalence of the measles, rubella, varicella-zoster, and mumps virus antibody titers in Japanese pregnant women.
    Hanaoka M; Hisano M; Watanabe N; Sugawara K; Kambe Y; Kanda E; Sago H; Kato T; Yamaguchi K
    Vaccine; 2013 May; 31(19):2343-7. PubMed ID: 23523405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Susceptibility of pregnant women to rubella and the implications of immunization programs].
    Villalbí JR; Graells C; Marín T
    An Esp Pediatr; 1988 Feb; 28(2):137-40. PubMed ID: 3355032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rubella control in Papua New Guinea: age-specific immunity informs strategies for introduction of rubella vaccine.
    Riddell M; Senn N; Clements CJ; Hobday L; Cowie B; Kurubi J; Kevin A; Siba P; Reeder JC; Morgan C
    Vaccine; 2012 Dec; 30(52):7506-12. PubMed ID: 23103194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of rubella vaccination programme on serological status of young adults in United Kingdom.
    Clarke M; Schild GC; Boustred J; Seagroatt V; Pollock TM; Finlay SE; Barbara JA
    Lancet; 1979 Jun; 1(8128):1224-6. PubMed ID: 87687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The active offering of measles, rubella and mumps vaccine in new mothers: the experience of health facilities in one of the Local Health Unit of Rome, Lazio, Italy].
    Santoro V; Pettinicchio V; Lancia A; Vazzoler C; De Luca F; Franco E
    Ig Sanita Pubbl; 2016; 72(6):589-597. PubMed ID: 28214912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].
    Vázquez Fernández E; López Rois F; Vázquez Carrete JA; Gómez Tato B; Alvarez Ares M
    An Esp Pediatr; 1987 Jul; 27(1):27-31. PubMed ID: 3662251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The status of rubella immunity among pregnant women in Kuwait: screening in childbearing age should be reintroduced.
    Makhseed M; Moussa MA; Ahmed MA; Abdulla N
    Acta Trop; 2001 Jan; 78(1):35-40. PubMed ID: 11164749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epidemiology of rubella in England and Wales before and after the 1994 measles and rubella vaccination campaign: fourth joint report from the PHLS and the National Congenital Rubella Surveillance Programme.
    Miller E; Waight P; Gay N; Ramsay M; Vurdien J; Morgan-Capner P; Hesketh L; Brown D; Tookey P; Peckham C
    Commun Dis Rep CDR Rev; 1997 Feb; 7(2):R26-32. PubMed ID: 9046126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rubella susceptibility in pregnant women and results of a postpartum immunization strategy in Catalonia, Spain.
    Vilajeliu A; García-Basteiro AL; Valencia S; Barreales S; Oliveras L; Calvente V; Goncé A; Bayas JM
    Vaccine; 2015 Apr; 33(15):1767-72. PubMed ID: 25731790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epidemiologic situation of rubella in Italy 20 years after the introduction of the vaccine].
    Galli MG
    Ann Ig; 1989; 1(1-2):247-54. PubMed ID: 2483071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility to rubella in a pregnant population after the introduction of vaccination.
    Broadbent E; Ajina N; Hurley R
    J Clin Pathol; 1980 Jan; 33(1):24-7. PubMed ID: 7358856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of rubella prevention in Austria (1988 status)].
    Hofmann H; Kunz C
    Wien Med Wochenschr; 1989 Jul; 139(14):330-3. PubMed ID: 2773490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rubella immune status in general practice.
    Yelland MJ
    Aust Fam Physician; 1989 Oct; 18(10):1279-81, 1284-5. PubMed ID: 2818317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rubella susceptibility predicts measles susceptibility: implications for postpartum immunization.
    Libman MD; Behr MA; Martel N; Ward BJ
    Clin Infect Dis; 2000 Dec; 31(6):1501-3. PubMed ID: 11096023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rubella, rubeola, and mumps in pregnant women: susceptibilities and strategies for testing and vaccinating.
    Haas DM; Flowers CA; Congdon CL
    Obstet Gynecol; 2005 Aug; 106(2):295-300. PubMed ID: 16055578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective immunization: protection of the individual.
    Dudgeon JA
    Rev Infect Dis; 1985; 7 Suppl 1():S185-90. PubMed ID: 4001726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.